Pluri PLUR
NASDAQ PLUR
$1.71 -0.05 (-2.84%)
As of: Aug 21, 2026 · 3:59 PM EDT

Pluri (PLUR) Cash from Financing Activities (2010 - 2025)

Pluri (PLUR) posted quarterly Cash from Financing Activities of -$435000.0 for Q2 2025, down 4250.0% quarter-over-quarter from -$10000.0 in Q2 2023.

Pluri (PLUR) Cash from Financing Activities (2010 - 2025) Analysis & Trends

Pluri (PLUR) has reported Cash from Financing Activities for 14 consecutive years, with -$435000.0 the latest figure, recorded in Q2 2025.

  • In Q2 2025, Cash from Financing Activities changed N/A year-over-year to -$435000.0; the TTM figure through Jun 2025 stood at $1.9 million (changed N/A YoY), while the FY2025 annual figure was $9.5 million, up 7.83% from the prior year.
  • Cash from Financing Activities declined to -$435000.0 in Q2 2025 per PLUR's latest filing, from -$10000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $35.7 million in Q1 2021 and bottomed at -$435000.0 in Q2 2025.
  • Historically, Cash from Financing Activities has averaged $12.4 million across 3 years, with a median of $2.3 million in 2023.
  • On a YoY basis, Cash from Financing Activities climbed as much as 561.87% in 2021 and fell as far as 50.69% in 2021.
  • Pluri's Cash from Financing Activities stood at $24.4 million in 2021, then slumped by 100.04% to -$10000.0 in 2023, then plunged by 4250.0% to -$435000.0 in 2025.
  • Business Quant data shows PLUR's Cash from Financing Activities at -$435000.0 in Q2 2025, -$10000.0 in Q2 2023, and $2.3 million in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 14.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -6.05 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 36.24 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -16.65 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 27.18 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -273.15 Mn
10 Pluri 16.21 Mn 3.72 Mn 86,000.00 -

Historic Data

Download Data
DateValue
Jun 30, 2025 -435,000.00
Jun 30, 2025 -435,000.00
Jun 30, 2023 -10,000.00
Jun 30, 2023 -10,000.00
Mar 31, 2023 2.34 Mn
Mar 31, 2023 2.34 Mn
Jun 30, 2021 24.41 Mn
Jun 30, 2021 24.41 Mn
Mar 31, 2021 35.71 Mn
Mar 31, 2021 35.71 Mn
Dec 31, 2020 984,000.00
Dec 31, 2020 984,000.00
Sep 30, 2020 300,000.00
Sep 30, 2020 300,000.00
Jun 30, 2020 49.51 Mn
Jun 30, 2020 49.51 Mn
Mar 31, 2020 5.40 Mn
Mar 31, 2020 5.40 Mn
Dec 31, 2019 3.99 Mn
Dec 31, 2019 3.99 Mn